Mal-Deferoxamine is a maleimide-functionalized derivative of Deferoxamine in which the maleamide group enables highly selective and covalent conjugation with thiol-containing biomolecules, forming stable linkages suited for chemical biology and radiopharmaceutical engineering. Mal-Deferoxamine readily chelates medical radionuclides to generate radionuclide drug conjugates (RDCs), which permit targeted molecular imaging or therapeutic delivery owing to their ability to engage specific biomolecular targets with high affinity, making this compound a versatile scaffold for the development of diagnostic probes and radiotheranostic agents.
